ARCH Venture Fund VIII, L.P.
Related Filers (13)
- CRANDELL KEITH (16)
- BYBEE CLINTON (16)
- ARCH Venture Partners VIII, LLC (16)
- ARCH Venture Partners VIII, L.P. (16)
- ARCH Venture Fund VIII Overage, L.P. (11)
- NELSEN ROBERT (11)
- Denali Therapeutics Inc. (7)
- Sienna Biopharmaceuticals, Inc. (6)
- Homology Medicines, Inc. (5)
- Scholar Rock Holding Corp (5)
- Codiak BioSciences, Inc. (5)
- Kura Oncology, Inc. (4)
- Metacrine, Inc. (3)
- Show More ...
Other (2)
D/A
Wednesday, 8/27/2014
Exempt (Private) Offering
D
Thursday, 4/24/2014
Exempt (Private) Offering
Ownership (35)
SC 13G/A
Wednesday, 2/14/2024
Scholar Rock Holding Corp: Major Shareholders
SC 13D
Tuesday, 9/20/2022
Codiak BioSciences, Inc.: Major Shareholders
4
Thursday, 9/15/2022
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/8/2022
Denali Therapeutics Inc.: Major Shareholders
SC 13G
Thursday, 2/4/2021
Codiak BioSciences, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/2/2021
Denali Therapeutics Inc.: Major Shareholders
SC 13G
Tuesday, 2/2/2021
Metacrine, Inc.: Major Shareholders
4
Tuesday, 10/20/2020
Codiak BioSciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/13/2020
Codiak BioSciences, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/22/2020
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/15/2020
Metacrine, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 2/13/2020
Homology Medicines, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/13/2020
Scholar Rock Holding Corp: Major Shareholders
SC 13G/A
Thursday, 2/13/2020
Denali Therapeutics Inc.: Major Shareholders
4
Monday, 8/12/2019
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/23/2019
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 3/6/2019
Sienna Biopharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 2/26/2019
Sienna Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/14/2019
Kura Oncology, Inc.: Major Shareholders
SC 13G
Thursday, 2/14/2019
Homology Medicines, Inc.: Major Shareholders
SC 13G
Thursday, 2/14/2019
Scholar Rock Holding Corp: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
Sienna Biopharmaceuticals, Inc.: Major Shareholders
4
Thursday, 5/31/2018
Scholar Rock Holding Corp: Statement of changes in beneficial ownership of securities
3
Wednesday, 5/23/2018
Scholar Rock Holding Corp: Initial statement of beneficial ownership of securities
4
Wednesday, 4/4/2018
Homology Medicines, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/27/2018
Homology Medicines, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 2/2/2018
Sienna Biopharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 2/2/2018
Denali Therapeutics Inc.: Major Shareholders
4
Tuesday, 12/12/2017
Denali Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/7/2017
Denali Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 8/1/2017
Sienna Biopharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/26/2017
Sienna Biopharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 2/13/2017
Kura Oncology, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2016
Kura Oncology, Inc.: Major Shareholders
SC 13G
Friday, 3/13/2015
Kura Oncology, Inc.: Major Shareholders